Copperleaf Capital LLC Purchases 121 Shares of Veeva Systems Inc. (NYSE:VEEV)

Copperleaf Capital LLC boosted its position in Veeva Systems Inc. (NYSE:VEEV) by 4.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,606 shares of the technology company’s stock after purchasing an additional 121 shares during the quarter. Copperleaf Capital LLC’s holdings in Veeva Systems were worth $548,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in VEEV. MassMutual Private Wealth & Trust FSB raised its holdings in Veeva Systems by 72.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock worth $25,000 after purchasing an additional 50 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of Veeva Systems during the third quarter valued at about $26,000. True Wealth Design LLC increased its holdings in shares of Veeva Systems by 3,375.0% during the third quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock valued at $29,000 after acquiring an additional 135 shares in the last quarter. Avion Wealth increased its holdings in shares of Veeva Systems by 635.0% during the fourth quarter. Avion Wealth now owns 147 shares of the technology company’s stock valued at $30,000 after acquiring an additional 127 shares in the last quarter. Finally, Retirement Wealth Solutions LLC acquired a new position in shares of Veeva Systems during the fourth quarter valued at about $31,000. 88.20% of the stock is currently owned by institutional investors.

Insider Activity at Veeva Systems

In other Veeva Systems news, SVP Jonathan Faddis sold 1,694 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $230.30, for a total value of $390,128.20. Following the completion of the sale, the senior vice president now directly owns 8,061 shares of the company’s stock, valued at $1,856,448.30. This trade represents a 17.37 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 10.50% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently issued reports on VEEV. Scotiabank upped their price objective on shares of Veeva Systems from $235.00 to $240.00 and gave the company a “sector perform” rating in a report on Friday, December 6th. Morgan Stanley upped their price objective on shares of Veeva Systems from $183.00 to $195.00 and gave the company an “underweight” rating in a report on Tuesday, December 17th. The Goldman Sachs Group downgraded shares of Veeva Systems from a “buy” rating to a “sell” rating and cut their price target for the stock from $261.00 to $200.00 in a report on Thursday, January 23rd. StockNews.com downgraded shares of Veeva Systems from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Finally, Truist Financial cut their price target on shares of Veeva Systems from $261.00 to $210.00 and set a “hold” rating on the stock in a report on Monday, January 13th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and seventeen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Veeva Systems has an average rating of “Moderate Buy” and an average price target of $253.96.

Veeva Systems Stock Performance

NYSE VEEV opened at $234.09 on Friday. The business has a fifty day moving average price of $224.48 and a 200 day moving average price of $215.96. Veeva Systems Inc. has a one year low of $170.25 and a one year high of $258.93. The company has a market cap of $38.00 billion, a P/E ratio of 57.80, a P/E/G ratio of 1.97 and a beta of 0.85.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.